1. Home
  2. NTRA vs KB Comparison

NTRA vs KB Comparison

Compare NTRA & KB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$261.99

Market Cap

39.1B

Sector

Health Care

ML Signal

HOLD

Logo KB Financial Group Inc

KB

KB Financial Group Inc

HOLD

Current Price

$117.43

Market Cap

38.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
KB
Founded
2003
2008
Country
United States
South Korea
Employees
N/A
N/A
Industry
Medical Specialities
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
39.1B
38.3B
IPO Year
2015
2008

Fundamental Metrics

Financial Performance
Metric
NTRA
KB
Price
$261.99
$117.43
Analyst Decision
Strong Buy
Analyst Count
15
0
Target Price
$259.07
N/A
AVG Volume (30 Days)
1.3M
300.1K
Earning Date
05-07-2026
04-23-2026
Dividend Yield
N/A
2.31%
EPS Growth
0.65
N/A
EPS
N/A
N/A
Revenue
$210,939,000.00
N/A
Revenue This Year
$18.08
$18.22
Revenue Next Year
$19.65
$3.21
P/E Ratio
N/A
$9.90
Revenue Growth
N/A
N/A
52 Week Low
$131.81
$76.31
52 Week High
$288.04
$125.62

Technical Indicators

Market Signals
Indicator
NTRA
KB
Relative Strength Index (RSI) 52.98 55.57
Support Level $261.63 $98.93
Resistance Level $288.04 $119.71
Average True Range (ATR) 10.37 2.67
MACD -3.55 -0.10
Stochastic Oscillator 23.31 40.50

Price Performance

Historical Comparison
NTRA
KB

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About KB KB Financial Group Inc

KB Financial Group Inc. is a financial holding company in Korea. The company operations include Kookmin Bank, one of the commercial banks in Korea. The company's subsidiaries collectively engage in a broad range of businesses, including commercial banking, credit cards, asset management, non-life and life insurance, capital markets activities, and international banking and finance. The company's segments include the Banking business, Securities business, Non-life Insurance business, Credit card business, and Life Insurance business. The Group generates the majority of its revenue from the Banking business.

Share on Social Networks: